{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:04:29Z","timestamp":1791144269454,"version":"4.1.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1097\/fpc.0000000000000022","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T09:25:13Z","timestamp":1386581113000},"page":"52-61","source":"Crossref","is-referenced-by-count":37,"title":["Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line"],"prefix":"10.1097","volume":"24","author":[{"given":"Karin","family":"Skoglund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Boiso Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Ingvar","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svante","family":"Vikingsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Gr\u00e9en","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2404897","article-title":"Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2.","volume":"22","author":"Shukla","year":"2008","journal-title":"Leukemia"},{"key":"R12-7-20210213","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2006-02-003145","article-title":"Functional ABCG2 is overexpressed on primary CML CD34 cells and is inhibited by imatinib mesylate.","volume":"108","author":"Jordanides","year":"2006","journal-title":"Blood"},{"key":"R22-7-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.4.1.1","article-title":"ABCG2: structure, function and role in drug response.","volume":"4","author":"Polgar","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R23-7-20210213","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"R24-7-20210213","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.talanta.2010.11.028","article-title":"A non-radioactive assay for precise determination of intracellular levels of imatinib and its main metabolite in Bcr-Abl positive cells.","volume":"83","author":"Mlejnek","year":"2011","journal-title":"Talanta"},{"key":"R25-7-20210213","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00277-010-1142-7","article-title":"Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells.","volume":"90","author":"Mlejnek","year":"2011","journal-title":"Ann Hematol"},{"key":"R27-7-20210213","first-page":"63","article-title":"ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro.","volume":"6","author":"Skoglund","year":"2013","journal-title":"Pharmgenomics Pers Med"},{"key":"R34-7-20210213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.clpt.6100268","article-title":"Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia.","volume":"83","author":"Wang","year":"2008","journal-title":"Clin Pharmacol Ther"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:21:47Z","timestamp":1620951707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201401000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000022","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}